Metabolic Stability Across Aging One of the most consistent findings in MOTS-c research is its ability to maintain glucose tolerance and insulin sensitivity, even in older test subjects
Peptides More Likely to Cause Site Reactions While most patients tolerate peptides well, the following are more likely to cause localized reactions , especially in sensitive individuals: CJC-1295 (with DAC) tends to be more inflammatory than without DAC LL-37 antimicrobial peptides can activate immune cells at the injection site KPV rare but possible immune stimulation during early use Thymosin Alpha 1 due to its immunomodulatory effects GHK-Cu may irritate if not well diluted Discuss any sensitivities or history of skin reactions with your provider before starting therapy
Temperature fluctuations, freeze-thaw cycles, shaking, and high concentrations all promote aggregation
doi: 10.1016/j.yexmp.2021.104617 276 YangXLiJWuYNiBZhangB
A 2006 Phase I trial of CJC-1295 reported no serious adverse events across a small number of subjects, but it was a safety study, not an outcomes trial, and there are no large trials showing it does what enthusiasts hope
